HighTower Advisors LLC lowered its stake in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) by 17.0% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 13,132 shares of the company’s stock after selling 2,685 shares during the period. HighTower Advisors LLC owned 0.07% of OrthoPediatrics worth $836,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Sageworth Trust Co acquired a new position in OrthoPediatrics during the first quarter worth $46,000. Maverick Capital Ltd. acquired a new position in OrthoPediatrics during the first quarter worth $65,000. Advisor Group Holdings Inc. raised its position in OrthoPediatrics by 49.1% in the second quarter. Advisor Group Holdings Inc. now owns 1,199 shares of the company’s stock valued at $76,000 after purchasing an additional 395 shares during the period. Spectrum Management Group LLC purchased a new stake in OrthoPediatrics in the second quarter valued at $102,000. Finally, SG Americas Securities LLC purchased a new stake in OrthoPediatrics in the first quarter valued at $139,000. 76.18% of the stock is currently owned by institutional investors.
OrthoPediatrics stock opened at $66.34 on Tuesday. The stock has a market capitalization of $1.31 billion, a price-to-earnings ratio of -39.02 and a beta of 0.69. The stock has a 50 day moving average of $65.11 and a two-hundred day moving average of $58.93. OrthoPediatrics Corp. has a twelve month low of $38.01 and a twelve month high of $72.50.
In related news, Director Stephen F. Burns sold 1,000 shares of the business’s stock in a transaction that occurred on Friday, August 27th. The stock was sold at an average price of $65.14, for a total transaction of $65,140.00. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Bernie B. Berry III sold 2,000 shares of the company’s stock in a transaction on Monday, August 2nd. The shares were sold at an average price of $66.60, for a total value of $133,200.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 11,321 shares of company stock worth $780,217. Corporate insiders own 30.30% of the company’s stock.
A number of research firms have commented on KIDS. JMP Securities lifted their target price on OrthoPediatrics from $70.00 to $77.00 and gave the company an “outperform” rating in a research report on Friday, August 6th. Needham & Company LLC lifted their target price on OrthoPediatrics from $70.00 to $77.00 and gave the company a “buy” rating in a research report on Monday, June 14th. Piper Sandler lifted their target price on OrthoPediatrics from $70.00 to $80.00 and gave the company an “overweight” rating in a research report on Thursday, August 5th. Finally, Zacks Investment Research upgraded OrthoPediatrics from a “hold” rating to a “buy” rating and set a $77.00 price objective on the stock in a report on Wednesday, August 11th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company currently has an average rating of “Buy” and an average target price of $73.14.
OrthoPediatrics Corp. is a medical device company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. Its products includes PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, RESPONSE Spine, Bandloc and Pediguard.
Read More: Market Timing – The Benefits and the Danger
Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.